OpenSource Lab-on-a-Chip physiometer for accelerated zebrafish embryo biotests

Current Protocols in Cytometry

Volumn , Issue SUPPL.67, 2014, Pages

  Akagi, Jin ^a   Hall, Chris J ^b   Crosier, Kathryn E ^b   Cooper, Jonathan M ^c   Crosier, Philip S ^b   Wlodkowic, Donald ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Bioassay; Biotest; Embryo; Lab on a Chip; Microfluidics; Opensource; PDMS; Pharmacology; Toxicology; Zebrafish

Indexed keywords

ARTICLE; BIOASSAY; CHEMICAL BINDING; CLINICAL PROTOCOL; ECOTOXICOLOGY; EMBRYO; EMBRYO CULTURE; EXPERIMENTAL DESIGN; HEATING; HYDRODYNAMICS; IMMOBILIZATION; LAB ON A CHIP; LABORATORY DEVICE; MALE; MICROFLUIDICS; NONHUMAN; PHENOTYPE; PHYSIOMETER; PRIORITY JOURNAL; ROOM TEMPERATURE; TEMPERATURE SENSITIVITY; TIME LAPSE IMAGING; ZEBRA FISH;

EID: 84905694065     PISSN: 19349297     EISSN: 19349300     Source Type: Journal    
DOI: 10.1002/0471142956.cy0944s67     Document Type: Article

References (26)

1. Akagi, J., Khoshmanesh, K., Evans, B., Hall, C.J., Crosier, K.E., Cooper, J.M., Crosier, P.S., and Wlodkowic, D. 2012a. Miniaturized embryo array for automated trapping, immobilization and microperfusion of zebrafish embryos. PLoS One 7:e36630.
2. Akagi, J., Khoshmanesh, K., Hall, C.J., Cooper, J.M., Crosier, K.E., Crosier, P.S., and Wlodkowic, D. 2012b. Fish on chips: Microfluidic living embryo array for accelerated in vivo angiogenesis assays. Sensors Actuators B 189:11-20.
3. Buchanan, C.M., Shih, J.H., Astin, J.W., Rewcastle, G.W., Flanagan, J.U., Crosier, P.S., and Shepherd, P.R. 2012. DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular. Clin. Sci. 122: 449-457.
4. Chakraborty, C., Hsu, C.H., Wen, Z.H., Lin, C.S., and Agoramoorthy, G. 2009. Zebrafish: A complete animal model for in vivo drug discovery and development. Curr. Drug Metab. 10:116-124.
5. Chiu, L.L., Cunningham, L.L.,Raible,D.W.,Rubel, E.W., and Ou, H.C. 2008. Using the zebrafish lateral line to screen for ototoxicity. Jaro-J Assoc. Res. Oto. 9:178-190.
6. Eimon, P.M. and Rubinstein, A.L. 2009. The use of in vivo zebrafish assays in drug toxicity screening. Exp. Opin.DrugMetab. Toxicol. 5:393-401.
7. Evensen, L., Link, W., and Lorens, J.B. 2010. Imaged-based high-throughput screening for anti-angiogenic drug discovery. Curr. Pharm. Design 16:3958-3963.
8. Huang, X.Q., Nguyen, A.T., Li, Z., Emelyanov, A., Parinov, S., and Gong, Z.Y. 2011. One step forward: The use of transgenic zebrafish tumor model in drug screens. Birth Defects Res. C 93:173-181.
9. Kamei, M., Isogai, S., Pan, W.P., and Weinstein, B.M. 2010. Imaging blood vessels in the zebrafish. Methods Cell Biol. 100:27-54.
10. Khoshmanesh, K., Akagi, J., Hall, C.J., Crosier, K.E., Crosier, P.S., Cooper, J.M., and Wlodkowic, D. 2012. New rationale for large metazoan embryo manipulations on chip-based devices. Biomicrofluidics 6:24102-2410214.
11. Kidd, K.R. and Weinstein, B.M. 2003. Fishing for novel angiogenic therapies. Br. J. Pharmacol. 140:585-594.
12. Kusik, B.W., Carvan, M.J. 3rd, and Udvadia, A.J. 2008. Detection of mercury in aquatic environments using EPRE reporter zebrafish. Mar. Biotechnol. 10:750-757.
13. Kuster, E. and Altenburger, R. 2008. Oxygen decline in biotesting of environmental samples-is there a need for consideration in the acute zebrafish embryo assay? Environ. Toxicol. 23:745-750.
14. Lammer, E., Carr, G.J., Wendler, K., Rawlings, J.M., Belanger, S.E., and Braunbeck, T. 2009a. Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? Comp. Biochem. Physiol. C 149:196-209.
15. Lammer, E., Kamp, H.G., Hisgen, V., Koch, M., Reinhard, D., Salinas, E.R., Wendler, K., Zok, S., and Braunbeck, T. 2009b. Development of a flow-through system for the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). Toxicol. In Vitro 23:1436-1442.
16. Lawson, N.D. and Weinstein, B.M. 2002. In vivo imaging of embryonic vascular development using transgenic zebrafish. Develop. Biol. 248:307-318.
17. Lieschke, G.J. and Currie, P.D. 2007. Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 8:353-367.
18. Okuda, K.S., Astin, J.W., Misa, J.P., Flores, M.V., Crosier, K.E., and Crosier, P.S. 2012. lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development 139:2381-2391.
19. Pardo-Martin, C., Chang, T.Y., Koo, B.K., Gilleland, C.L., Wasserman, S.C., and Yanik, M.F. 2010. High-throughput in vivo vertebrate screening. Nat. Methods 7:634-636.
20. Parng, C. 2005. In vivo zebrafish assays for toxicity testing. Curr. Opin. Drug Discov. 8:100-106.
21. Parng, C., Seng, W.L., Semino, C., and McGrath, P. 2002. Zebrafish: A preclinical model for drug screening. Assay Drug Dev. Technol. 1: 41-48.
22. Sia, S.K. and Whitesides, G.M. 2003. Microfluidic devices fabricated in poly(dimethylsiloxane) for biological studies. Electrophoresis 24:3563-3576.
23. Tan, W.H. and Takeuchi, S. 2007. A trapand-release integrated microfluidic system for dynamic microarray applications. Proc. Natl. Acad. Sci. U.S.A. 104:1146-1151.
24. Tan, W.H. and Takeuchi, S. 2008. Dynamic microarray systemwith gentle retrievalmechanism for cell-encapsulating hydrogel beads. Lab Chip 8:259-266.
25. Weigt, S., Huebler, N., Strecker, R., Braunbeck, T., and Broschard, T.H. 2011. Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicology 281:25-36.
26. Wlodkowic, D., Khoshmanesh, K., Akagi, J., Williams, D.E., and Cooper, J.M. 2011. Wormometry-on-a-chip: Innovative technologies for in situ analysis of small multicellular organisms. Cytometry A 79:799-813.